TOP TIERMARKET NEWSWIRE
SEC Form 4 history

DEFINIUM THERAPEUTIC (DFTX) insider trades

DEFINIUM THERAPEUTIC (DFTX) insider trading activity (SEC Form 4). Over the trailing 90 days, DFTX insiders filed 0 purchases totalling $0 and 6 sales totalling $3.0M — net SELLING of $3.0M. Most recent filing: Sep 29, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$3.0M
Net (90d)
-$3.0M
net selling
Most recent
Sep 29, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 29, 2026Karlin DanielChief Medical OfficerS Sale—$36.57$397Kfiling
Sep 29, 2026Barrow RobertCEOS Sale—$36.57$1.2Mfiling
Sep 29, 2026Wiley Matthew T.Chief Commercial OfficerS Sale—$36.57$113Kfiling
Sep 29, 2026Sullivan MarkGCS Sale—$36.57$514Kfiling
Sep 29, 2026Roberts BrandiCFOS Sale—$36.57$123Kfiling
Sep 4, 2026Barrow RobertCEOS Sale—$37.94$722Kfiling
Jun 26, 2026Wiley Matthew T.Chief Commercial OfficerS Sale—$45.03$129Kfiling
Jun 26, 2026Karlin DanielChief Medical OfficerS Sale—$45.03$452Kfiling
Jun 26, 2026Barrow RobertCEOS Sale—$45.03$1.3Mfiling
Jun 26, 2026Roberts BrandiCFOS Sale—$45.03$136Kfiling
Jun 26, 2026Sullivan MarkGCS Sale—$45.03$586Kfiling